A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

NCT02889666 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Docetaxel
DRUG: Gemcitabine/Carboplatin
DRUG: Gemcitabine/Cisplatin
DRUG: Docetaxel/Oxaliplatin
DRUG: Docetaxel/Carboplatin
DRUG: Placebo

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]